InvestorsHub Logo
Followers 829
Posts 119628
Boards Moderated 14
Alias Born 09/05/2002

Re: DewDiligence post# 731

Wednesday, 01/26/2022 11:13:24 AM

Wednesday, January 26, 2022 11:13:24 AM

Post# of 803
ABT 2021 non-GAAP EPS=$5.21, above the prior guidance range of $5.00-5.10 due to a surge in COVID diagnostics sales in December related to Omicron.

ABT’s 2022 non-GAAP-EPS guidance is >=$4.70 (-10% YoY) due to lower expected sales of COVID diagnostics, which were $7.7B(!) in 2021 and $2.3B in 4Q21.

4Q21 PR:
https://abbott.mediaroom.com/2022-01-26-Abbott-Reports-Strong-Fourth-Quarter-2021-Results-Issues-2022-Forecast

1-page summary sheet:
https://www.abbottinvestor.com/static-files/d7299f5f-28d7-4f48-aaf8-729bfc7c4157

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABT News